Moderna Inc. is pioneering personalized cancer treatments using mRNA technology to create bespoke drugs for individual patients. By sequencing each patient’s tumor DNA and matching it with neoantigens, they aim to train the immune system to destroy cancer. While early results show promise, challenges remain in scaling up production and treating different types of tumors.









